Last reviewed · How we verify
NCT05755139
Safety and Efficacy Evaluation of SMART Camera Treatment Presets for Cutaneous Lesions Using IPL
NA trial testing IPL with smart diagnostic handpiece in Vascular Lesion in 60 participants. Completed in 15 August 2023.
23 June 2023
Quick facts
| Lead sponsor | Lumenis Be Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 4 December 2022 |
| Primary completion | 23 June 2023 |
| Estimated completion | 15 August 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- IPL with smart diagnostic handpiece
Conditions studied
- Vascular Lesion — all drugs for Vascular Lesion →
- Pigmented Lesions — all drugs for Pigmented Lesions →
Sponsor
Lumenis Be Ltd. — full company profile →
Who can join
Adults 21 to 80, any sex, with Vascular Lesion or Pigmented Lesions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multi-center, Prospective, Open-Label with Before-After Study Design. Each subject will receive a single treatment. Treatment presets will be determined by the SMART Camera system and approved by the physician. Follow-up will take place at 1 month following the treatment. Skin and lesion attributes will be examined by the SMART system and the physician
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05755139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vascular Lesion
Currently open trials in the same condition.
- NCT07012668 — Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery · recruiting
- NCT06230731 — Oxygenation in Vascular Lesions of the Colon · NA · recruiting
- NCT06655129 — Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder · NA · recruiting
Other Lumenis Be Ltd. trials
Trials by the same sponsor.
- NCT07039461 — Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion · NA · terminated
- NCT06885112 — Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser · NA · recruiting
- NCT05945069 — Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease · NA · completed
- NCT05957029 — Evaluation of Thermal Outcome and Safety of Nuera Tight RF System · NA · completed
- NCT05773924 — Evaluation of Efficacy and Safety of the triLift™ System · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05755139 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lumenis Be Ltd.
- Last refreshed: 22 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05755139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing